Actively Recruiting
Pre-marketing Trial to Assess Safety and Efficacy of 'Volumizing Filler Based on Hyaluronic Acid and Recombinant Collagen'
Led by Taumedika s.r.l. · Updated on 2026-01-26
40
Participants Needed
1
Research Sites
17 weeks
Total Duration
On this page
Sponsors
T
Taumedika s.r.l.
Lead Sponsor
N
Nextrasearch S.r.l.s.
Collaborating Sponsor
AI-Summary
What this Trial Is About
Study to validate the safety and efficacy of the Hyaluronic Acid +Collagen filler 40 patients will undergo through 3 visits one to asses the health and apply the filler one after 4 weeks to check the results one after 16 weeks for the final check and results validation Safety assessed with analysis of the Adverse Events
CONDITIONS
Official Title
Pre-marketing Trial to Assess Safety and Efficacy of 'Volumizing Filler Based on Hyaluronic Acid and Recombinant Collagen'
Who Can Participate
Eligibility Criteria
You may qualify if you...
- All sexes
- Caucasian ethnicity
- Age between 18 and 70 years
- Non-smoker
You will not qualify if you...
- Pregnancy
- Breastfeeding
- Smoker
- Alcohol or drug abuse
- Significant change in BMI during the study
- Previous facial surgery, implants, or permanent treatments
- Sensitivity to the product
- Difficult dermatological conditions
- General health weakness
- Treatment with anticoagulants, antihistamines, corticosteroids, antidepressants, or other drugs affecting results
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Ospedale Tor Vergata
Roma, Italy, 00133
Actively Recruiting
Research Team
E
Elena Campione, Professor
CONTACT
A
Adolfo Gasparetto, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here